Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene

Shock

Volumn 13, Issue 6, 2000, Pages 413-424

  Taylor, Bradley S ^a   Geller, David A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Gene expression; Heat shock; I B; Inducible nitric oxide synthase (iNOS); Inflammation; Nitric oxide (NO); Nuclear factor kappa B (NF B); P53; Transcription

Indexed keywords

GROWTH PROMOTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; NOS2A PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CELL STRAIN 3T3; DRUG EFFECT; ENHANCER REGION; ENZYME INDUCTION; ENZYMOLOGY; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LIVER; MOUSE; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

3T3 CELLS; ANIMALS; ENHANCER ELEMENTS (GENETICS); ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES; GROWTH SUBSTANCES; HUMANS; LIVER; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034199889     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200006000-00001     Document Type: Review

References (105)

1. Moncada S, Higgs EA: Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 21:361-374, 1991
2. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH: Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351:714-718, 1991
3. Sessa WC, Harrison JK, Barber CM, Zeng D, Durieux ME, D'Angelo DD, Lynch KR, Peach MJ: Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem 267:15274-15276, 1992
4. Kronke KD, Fehsel K, Kolb-Bachofen V: Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113:147-156, 1998
5. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons RL, Peitzman AB: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214:621-626, 1991
6. Szabo C, Thiemermann C: Invited opinion: role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock 2:145-155, 1994
7. Cobb JP, Danner RL: Nitric oxide and septic shock. JAMA 275:1192-1196, 1996.
8. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 87:3629-3632, 1990.
9. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28:34-39, 1994.
10. G-methyl-L-arginine in cancer patients with shock. [Abstract 57] Endothelium 3:S15, 1995.
11. Harbrecht BG, Wu B, Watkins SC, Billiar TR, Peitzman AB: Inhibition of nitric oxide synthesis during severe shock but not after resuscitation increases hepatic injury and neutrophil accumulation in hemorrhaged rats. Shock :425-421, 1997.
12. Kilbourn RG, Szabo C, Traber DL: Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 7:235-246, 1997
13. Nussler A, Di Silvio M, Billiar TR, Hoffman RA, Geller DA, Selby R, Madriaga J, Simmons RL: Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 176: 261-264, 1992
14. Geller DA, Billiar TR: Molecular biology of inducible nitric oxide synthase. Cancer Mutat Res 17:7-23, 1997
15. Taylor BS, Alarcon LH, Billiar TR: Inducible nitric oxide synthase in the liver: regulation and function. Biochemistry (Moscow) 63:766-781, 1998
16. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvo M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar TR: Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90:3491-3495, 1993
17. Marsden PA, Schappert KT, Chen HS, Flowers M, Sundell CL, Wilcox JN, Lamas S, Michel T: Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 307:287-293, 1992
18. Janssens SP, Shimouchi A, Quertermous T, Bloch DB: Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267:14519-14522, 1992
19. Nakane M, Schmidt HHHW, Pollock JS, Forstermann U, Murad F: Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 316:175-180, 1993
20. Charles IG, Palmer RMJ, Hickery MS, Bayliss MT, Chubb AP, Hall VS, Moss DW, Moncada S: Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA 90:11419-11423, 1993
21. Maier R, Bilbe G, Rediske J, Cotz M: Inducible nitric oxide synthase from articular human chondrocytes: cDNA, cloning and analysis of mRNA expression. Biochem Biophys Acta 1208:145-150, 1994
22. Sherman PA, Laubach VE, Reep BR, Wood ER: Purification and cDNA sequence of an inducible nitric oxide synthase (NOS) from a human tumor cell line. Biochemistry 32:11600-11605, 1993
23. Hokari A, Zeniya M, Esumi H: Cloning and functional expression of human inducible nitric oxide synthase (NOS) from a glioblastoma cell line A-172. J Biochem 116:575-581, 1994
24. Luss H, Watkins SC, Freeswick PD, Imro AK, Nussler AK, Billiar TR, Simmons RL, del Nido PJ, McGowan FX Jr: Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J Mol Cell Cardiol 27:2015-2029, 1996
25. Chartrain N, Geller DA, Koty PP, Sitrin NF, Nussler AK, Hoffman EP, Billiar TR, Hutchinson NI, Mudgett JS: Molecular cloning, structure, chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 269;6765-6772, 1994
26. Marsden PA, Heab HHQ, Scherer SW, Stewart RJ, Hall AV, et al: Structural and chromosomal localization of the human constituitive endothelial nitric oxide synthase. J Biol Chem 268:17478-17488, 1993
27. Kishimoto J, Spurr N, Liao M, Lizhi L, Emsonp Xu W: Localization of brain nitric oxide synthase (NOS) to human chromosome 12. Genomics 14:802-804, 1992
28. Geller DA, de Vera ME, Russell DA, Shapiro RA, Nussler AK, Simmons RL, Billiar TR: A central role for interleukin-1b in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. J Immunol 155: 4890-4898, 1995
29. Arany I, Brysk MM, Brysk H, Tyring SK: Regulation of inducible nitric oxide synthase mRNA levels by differentiation and cytokines in human keratinocytes. Biochem Biophys Res Commun 220:618-622, 1996
30. Salzman AL, Denenberg AG, Ueta I, O'Connor M, Linn SC, Szabo C: Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am J Physiol 270:G565-G573, 1996.
31. Nussler AK, Vergani G, Gollin SM, Dorko K, Morris SM Jr, Demetris AJ. Nomoto M, Beger HG, Strom SC. Isolation and characterization of a human hepatic epithelial-like cell line (AKN-1) from a normal liver. In Vitro Cellular Dev Biol 35:190-197, 1999.
32. de Vera ME, Shapiro RA, Nussler AK, Mudgett JS., Simmons RL, Morris SM, Billiar TR, Geller DA: Transcriptional regulation of human inducible nitric oxide synthase (iNOS) gene by cytokines: initial analysis of the human iNOS promoter. Proc Natl Acad Sci USA 93:1054-1059, 1996
33. Taylor, BS, de Vera, ME, Ganster, RW, Wang, Q, Shapiro, RA, Morris, SM, Billiar TR, Geller DA: Multiple NFκB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 273:15148-15156, 1998
34. Xie QW, Whisnant R, Nathan C: Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial LPS. J Exp Med 177:1779-1785, 1993.
35. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ: Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 90:9730-9738, 1993
36. Laubach, VE, Zhang CX, Russell SW, Murphy WJ, Sherman PA: Analysis of expression and promoter function of the human inducible nitric oxide synthase gene in DLD-1 cells and monkey hepatocytes. Biochimica et Biophysica Acta 1351:287-295, 1997
37. Marks-Konczalik J, Chu SC, Moss J: Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor-κB-binding sites. J Biol Chem 273:22201-22208, 1998
38. Kolyada AY, Savikovsky N, Madias NE: Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: evidence for tissue specificity. Biochem Biophys Res Commun 220:600-605, 1996.
39. Linn, SC, Morelli PJ, Edry I, Cottongim SE, Szabo C, Salzman AL: Transcriptional regulation of human inducible nitric oxide synthase in an intestinal epithelial cell line. Am J Physiol 35:G1499-G1508, 1997
40. Spitsin SV, Farber JL, Bertovich M, Moehren G, Koprowski H, Michaels FH: Human-and mouse-inducible nitric oxide synthase gene promoters require activation of phosphatidylcholine-specific phospholipase C and NF-κB. Mol Med 3:315-326, 1997
41. Taylor, BS, Shao, LF, Gambotto, A, Ganster, RW, Geller, DA. Inhibition of cytokine-induced nitric oxide synthase (iNOS) expression by gene transfer of adenoviral IκBα. Surgery 126:142-147, 1999.
42. Montgomery KF, Osborn, L, Hession C, Tizard R, Goff D, Vassallo C, Tarr PI, Bomsztyk K, Lobb R, Harlan JM, Pohlman TH: Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc Natl Acad Sci USA 88:6523-6527, 1991
43. Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T: Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 176:1583-1593, 1992
44. Voraberger G, Schafer R, Stratowa, C: Cloning of the human gene for intracellular adhesion molecule 1 and analysis of its 5′-regulatory region. Induction by cytokines and phobol ester. J Immunol 147:2777-2786, 1991
45. Mukaida N, Mahe Y, Matsushima K. Cooperative interaction of nuclear factor-kappa B-and cis regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 265:21128-21133, 1990
46. Cogswell JP, Godlevski MM, Wisely GB, Clay WC, Leesnitzer LM, Ways JP, Gray JG: NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a non-consensus CRE-like site. J Immunol 153:712-723, 1994
47. Zhang L, Nabel GJ: Positive and negative regulation of IL-2 gene expression: role of multiple regulatory sites. Cytokines 6:221-228, 1994
48. Ohmori Y, Schreiber RD, Hamilton TA: Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J Biol Chem 272:14899-14907, 1997
49. Gao JJ, Filla MB, Fultz MJ, Vogel SN, Russell SW, Murphy WJ: Autocrine/paracrine IFNalpha-beta mediates lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha induction of the inducible nitric oxide synthase gene. J Immunol 161:4803-4810, 1998
50. Kleinert H, Wallerath T, Fritz G, Ihrig-Biedert I, Geller D, Forstermann U: Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1, and NF-κB-signaling pathways. Br J Pharmacol 125;1:193-201, 1998
51. Anstey NM. Weinberg JB. Hassanali MY. Mwaikambo ED. Manyenga D. Misukonis MA. Arnelle DR. Hollis D. McDonald MI. Granger DL: Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 184:557-567, 1996.
52. Kun JF, Mordmuller B, Lell B, Lehman LG, Luckner D, Kremsner PG: Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351:265-266, 1998.
53. Burgner D, Xu W, Rockett K, Gravenor M, Charles IG, Hill AV, Kwiatkowski D: Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet 52:1193-1194, 1998.
54. Xie Q-W, Kashiwabara Y, Nathan C: Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269: 4705-4708, 1994
55. Xie Q-W: A novel lipopolysaccharide-response element contributes to induction of nitric oxide synthase. J Biol Chem 272:14867-14872,1997
56. Goldring CE, Reveneau S, Algarte M, Jeannin JF: In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6. Nucl Acids Res 24:1682-1687, 1996
57. Sawada T, Falk LA, Padmini R, Murphy WJ, Pluznik DV: IL-6 induction of protein-DNA complexes via a novel regulatory region of the inducible nitric oxide synthase gene promoter: role of octamer binding proteins. J Immunol 158:5267-5276, 1997
58. Gay RD, Dawson SJ, Murphy WJ, Russell SW, Latchman DS: Activation of the iNOS gene promoter by Brn-3 POU family transcription factors is dependent upon the octamer motif in the promoter. Biochem Biophys Acta 1443:315-322, 1998
59. Dlaska M, Weiss G: Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J Immunol 162:6171-6177, 1999
60. Martin E, Nathan C, Xie QW: Role of interferon regulatory factor 1 in inducton of nitric oxide synthase. J Exp Med 180:977-984, 1994
61. Gao J, Morrison DC, Parmely TJ, Russell SW, Murphy WJ: An interferon-g-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-γ and LPS. J Biol. Chem 272:1226-1230, 1997
62. Gao JJ, Filla MB, Fultz MJ, Vogel SN, Russell SW, Murphy WJ: Autocrine/paracrine IFN-αβ mediates the lipopolysaccharide-induced activation of transcription factor Stat1a in mouse macrophages: Pivotal role of Stat1a in induction of the inducible nitric oxide synthase gene. J Immunol 161:4803-4810, 1998
63. Murphy WJ, Muroi M, Zhang CX, Suzuki T, Russell SW: Both basal and enhancer elements are required for full induction of the mouse inducible nitric oxide synthase gene. J Endotoxin Res 3:381-393, 1996
64. Spink, J, Cohen J, Evans TJ: The cytokine responsive vascular smooth musle cell enhancer of inducible nitric oxide synthase. J Biol Chem 270:29541-29547, 1995
65. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L: A hypoxia responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182:1683-1693, 1995
66. Zhang X, Laubach VE, Alley EW, Edwards KA, Sherman PA, Russell SW, Murphy WJ: Transcriptional basis for hyporepsonsiveness of human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-g. J Leukocyte Biol 59:575-585,1996
67. Bertholet S, Tzeng E, Felley-Bosco E, Mauel J: Expression of the induciible nitric oxide synthase in human monocytic U937 cells allows high output nitric oxide production. J Leukoc Biol 65:50-58, 1999
68. Weinberg JB. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. [Review] Mol Med 4:557-591, 1998.
69. Shaw G, Kamen R: A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667, 1986
70. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Serami A: Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 83:1670-1674, 1986
71. Han J, Brown T, Beutler B: Endotoxin-reponsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 171:465-475, 1990
72. Nunokawa Y, Oikawa S, Tanaka S: Expression of human inducible nitric oxide synthase is regulated by both promoter and 3′-regions. Biochem Biophys Res Commun 223:347-352, 1996
73. Chu SC, Wu HP, Banks TC, Eissa NT, Moss J: Structural diversity in the 5′-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA. J Biol Chem 270:10625-10630, 1995
74. Eissa NT, Strauss AJ, Haggerty CM, Choo EK, Chu SC, Moss J: Alternative splicing of human inducible nitric oxide synthase mRNA: tissue specific regulation and induction by cytokines. J Biol Chem 271:27184-27187, 1996
75. Eissa NT, Yuan JW, Haggerty CM, Choo EK, Palmer CD, Moss J: Cloning and characterizaion of human inducible nitric oxide synthase splic variant: a domain, encoded by exons 8 and 9, is critical for dimerization. Proc Natl Acad Sci USA 95:7625-7630, 1998
76. Pastor CM, Williams D, Yoneyama T, Hatakeyama K, Singleton, Naylor E, Billiar TR: Competition for tetrahydrobiopterin between phenylalanine hydroxylase and nitric oxide synthase in rat liver. J Biol Chem 271:24534-24538, 1996
77. Harada T, Kagamiyama H, Hatakeyama K: Feedback regulation mechanisms for the control of GTP cyclohydrolase I activity. Science 260: 1507-1510, 1993
78. Taylor BS, Liu S, Villavicencio RT, Ganster RW, Geller DA. The role protein of phosphatases in the expression of inducible nitric oxide synthase in the rat hepatocyte. Hepatology 29:1199-1207, 1999
79. Knowles RG, Salter M, Brooks SL, Moncada S: Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase. Biochem Biophys Res Commun 172:1042-1048, 1990
80. Geller DA, Nussler AK, Di Silvio M, Lowenstein CL, Shapiro RA, Wang SC, Simmons RL, Billiar TR: Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 90:522-526, 1993
81. Kleinert H, Euchenhofer C, Ihrig-Biedert I, Forstermann U: Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor NF-κB. Mol Pharmacol 1996;49:15-21, 1996
82. de Vera ME, Taylor BS, Wang Q, Shapiro RA, Billiar TR, Geller DA. dexamethasone suppresses inducible nitric oxide synthase gene expression by upregulating I-κBα and Inhibiting NF-κB. Am J Phys 273:G1290-G1296, 1997
83. Perrella MA, Yoshizumi M, Fen Z, Tsai J-C, Hsieh C-M, Kourembanas S, Lee M-E: Transforming growth factor-β1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1β in rat smooth muscle cells. J Biol Chem 269:14595-14600, 1994.
84. Kunz D, Walker G, Eberhardt W, Pfeilschifter J: Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1ß-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc Natl Acad Sci USA 93:255-259, 1996.
85. Taylor BS, Kim YM, Wang Q, Shapiro RA, Billiar TR, Geller DA. Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch Surg 132:1177-1183, 1997
86. Park SK, Lin HL, Murphy S: Nitric oxide regulates nitric oxide syntase-2 gene expression by inhibiting NF-κB binding to DNA. Biochem J 322: 609-613, 1997
87. Griscavage JM, Rogers NE, Sherman MP, Ignarro LJ: Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J Immunol 151:6329-6337, 1993
88. Colasanti M, Persichini T, Menegazzi M, Mariotto S, Giordano E Caldarera CM: Induction of nitric oxide synthase mRNA expression. Suppression by nitric oxide. J Biol Chem 270:26731-26733
89. Ambs S, Hussain SP, Harris C: Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 11:443-448, 1997
90. Forrester K, Ambs S, Lupold SE, Kapust RB, Spillare EA, Weinberg WC, Felley-Bosco E, Wang XW, Geller DA, Tzeng E, Billiar TR, Harris CC: Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci USA 93:2442-2447, 1996
91. Ambs S, Ogunfusika M, Merriam W, Bennett WP, Billiar TR, Harris CC: Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc Natl Acad Sci USA 95:8823-8828, 1998
92. de Vera ME, Wong J, Zhou JY, Tzeng E, Wong H, Billiar TR, Geller DA: Cytokine-induced nitric oxide synthesis in human liver cells is inhibited by the heat shock response. Surgery 120:144-149, 1996
93. Feinstein DL, Galca E, Aquino DA, Li GC, Xu H, Reis DJ. Heat shock protein 70 suppresses astroglial-inducible nitric oxide synthase expression by decreasing NF-κB activation. J Biol Chem 271:17724-17732, 1996.
94. Kim YM, de Vera ME Watkins SC, Billiar TR: Nitric oxide protects cultured rat hepatocytes from TNFα-induced apoptsosis by inducing heat shock protein 70 expression. J Biol Chem 272:1402-1411, 1997
95. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S: Macrophage deactivating factor and transforming growth factors-b1, -b2, and -b3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J Immunol 145:940-946, 1990.
96. Pfeilschifter J, Vosbeck K: Transforming growth factor-b2 inihibits interleukin-1β and tumor necrosis factor-α induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun 175: 372-375, 1991
97. Roberts AB, Vodovotz Y, Roche NS, Sporn MB, Nathan CF: Role of nitric oxide in antagonists effects of transforming growth factor-b and interleukin-1b on the beating rate of cultured cardiac myocytes. Mol Endocrinol 6:1921-1928, 1992
98. Perrella MA, Yoshizumi M, Fen Z, Tsai JC, Hseih CM, Kourembanas S, Lee ME: Transforming growth factor-b1, but not dexamethasone, down regulates nitric oxide synthase mRNA after its induction by interleukin-1b in rat smooth muscle cells. J Biol Chem 269:14595-14600, 1994
99. Perrella MA, Patterson C, Tan L, Yet SF, Hseih CM, Yoshizumi M , Lee ME: Suppression of interleukin 1-b induced nitric oxide synthase promoter/enhancer activity by transforming growth-b in vascular smooth muscle cells. J Biol Chem 271:13776-13780, 1996
100. Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C: Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-b. J Exp Med 178:605-613, 1993
101. Nussler AK, Di Silvio M, Liu Z-Z, Geller DA, Freeswick PD, Dorko K, Bartoli F, Billiar TR. Further characterization and comparison of inducible nitric oxide synthase in mouse, rat and human hepatocytes. Hepatology 1995; 21:1552-1560.
102. Gilbert RS, Herschman HR: Transforming growth factor beta differentially modulates the inducible nitric oxide synthase gene in distinct cell types. Biochem Biophys Res Commun 195:380-384, 1993
103. Kleinert, H, Euchenhofer C, Ihrig-Biedert I, Forstermann U: In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-kappaB. J Biol Chem 271:6039-6044, 1996
104. Liu ZZ, Cui S, Billiar TR, Dorko K, Halfter W, Geller DA, Michalopoulos G, Beger HG, Albina J, Nussler AK: Effects of hepatocellular mitogens on cytokine-induced nitric oxide synthesis in human hepatocytes. J leuk Biol 60:382-388, 1996.
105. Murphy, WJ. Transcriptional regulation of the gene encoding nitric oxide synthase. In: Laskin JL, Laskin DL (eds): Cellular and Molecular Biology of Nitric Oxide. New York: Marcel Dekker, 1999, pp 1-57.